September 10, 2025
Hospitalists dip into DKA
Protocols using subcutaneous insulin have brought diabetic ketoacidosis (DKA) into the domain of hospitalists.
Opioids get new labels
The FDA also announced an official end to the nationwide shortage of sodium chloride 0.9% injection products, among other actions.
Extended apixaban after provoked VTE reduced recurrence rate
In patients who had venous thromboembolism (VTE) provoked by a transient factor and a risk factor for recurrence, taking apixaban for 12 months led to a symptomatic recurrence rate of 1.3%, compared to 10.0% in those randomized to placebo, an industry-funded trial found.
Ivabradine doesn't reduce risk of MINS
A Polish trial was stopped early because patients who had or were at risk for atherosclerotic disease and were given ivabradine perioperatively had similar risk of myocardial injury after noncardiac surgery (MINS) as those randomized to placebo.
CNS-active medications increase readmission risk in older patients
For every central nervous system (CNS)-active medication an older patient with comorbidities was prescribed at discharge, their risk of readmission in the year after hospitalization increased by 7%, a European study found.
Cardiac problems more common than expected in Mycoplasma pneumoniae
Seventeen percent of hospitalized adults with M. pneumoniae infection had cardiac involvement, most commonly congestive heart failure and arrhythmias, a cohort study in Israel found.
Take a quiz about the Sept. 3 issue!
Every week, ACP Hospitalist posts a question about the previous week's issue. See how well you remember what you've read compared to other readers.